SCHEMBL3706503

SCHEMBL3706503

CN1CCC2(CC1)c1ccccc1CCC2C=O

nearest known ligand 0.44

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
MAPK1 P28482 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
KDM1A O60341 5/20 0.44
SIGMAR1 Q99720 4/20 0.44
HTR2A P28223 3/20 0.44
HTR2C P28335 3/20 0.44
HTR2B P41595 3/20 0.44
SRD5A1 P18405 1/20 0.43
GRIN2D O15399 1/20 0.41
GRIN3B O60391 1/20 0.41
GRIN1 Q05586 1/20 0.41
GRIN2A Q12879 1/20 0.41
GRIN2B Q13224 1/20 0.41
GRIN2C Q14957 1/20 0.41
GRIN3A Q8TCU5 1/20 0.41
MAOB P27338 1/20 0.40
OPRD1 P41143 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27870205 0.72 SRD5A1 (0.37) MAPK1SMN1; SMN2SRD5A1
SCHEMBL21845244 0.69 KDM1A (0.50) MAPK1SMN1; SMN2KDM1ASIGMAR1GRIN2D
SCHEMBL13262553 0.69 GRIN2D (0.50) MAPK1SMN1; SMN2KDM1ASIGMAR1GRIN2D
SCHEMBL10092817 0.68 MCHR2 (0.50) MAPK1SMN1; SMN2KDM1ASIGMAR1HTR2A
SCHEMBL2743258 0.66 SIGMAR1 (0.67) SIGMAR1HTR2AHTR2CHTR2B
SCHEMBL12021583 0.65 MAOA (0.47) MAPK1SMN1; SMN2KDM1ASIGMAR1HTR2A
SCHEMBL14193182 0.65 HTR2A (0.66) MAPK1SMN1; SMN2SIGMAR1HTR2AHTR2C
SCHEMBL1207260 0.65 SRD5A1 (0.45) MAPK1SMN1; SMN2KDM1ASIGMAR1HTR2A
SCHEMBL12389036 0.65 KDM1A (0.44) KDM1AGRIN1GRIN2AMAOB
SCHEMBL19031400 0.64 KDM1A (0.70) KDM1AMAOB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2207549-A1 MODULATORS OF MUSCARINIC RECEPTORS Vertex Pharmceuticals Incorporated (US) 2010-07-21 EP disclosed
WO-2009045519-A1 MODULATORS OF MUSCARINIC RECEPTORS VERTEX PHARMACEUTICALS INCORPORATED (US) 2009-04-09 WO disclosed